[Back to Issue 7 ToC] [Back to Journal Contents] [Back to Biochemistry (Moscow) Home page]

Activation of Ganglioside GM3 Biosynthesis in Human Monocyte/Macrophages during Culturing in vitro

E. V. Gracheva, N. N. Samovilova, N. K. Golovanova, E. R. Andreeva, I. V. Andrianova, E. M. Tararak, and N. V. Prokazova*

Institute of Experimental Cardiology, Cardiology Research Center, Russian Ministry of Health, 3-ya Cherepkovskaya ul. 15a, 121552 Moscow, Russia; fax: (495) 149-0559; E-mail: prokazova@cardio.ru

* To whom correspondence should be addressed.

Received February 20, 2007; Revision received March 23, 2007
We found that GM3 levels in human peripheral blood monocytes and cultured monocyte-derived macrophages were 0.37 and 2.7 µg per million cells, respectively. GM3 synthase of monocytes and to a greater extent of monocyte-derived macrophages was shown to be able to sialylate endogenous substrate, lactosylceramide (LacCer), to form GM3. With exogenously added LacCer, GM3 synthase activity was 57.1 and 563 pmol/h per mg protein in monocytes and monocyte-derived macrophages, respectively. The revealed changes in ganglioside GM3 biosynthesis are specific as the activity of some other sialyltransferases under these conditions was not altered. Human anti-GM3 synthase antibody detected in monocytes a main protein with molecular weight of 60 kD and minor proteins with molecular masses of 52 and 64 kD. In monocyte-derived macrophages the amounts of 60 kD protein and especially 64 kD protein sharply rose. Thus, the increase in ganglioside GM3 levels, GM3 synthase activity, and the enzyme amounts during culturing of monocyte/macrophages may be one of the mechanisms of in vivo increased ganglioside GM3 levels in arterial atherosclerotic lesions.
KEY WORDS: gangliosides, GM3 synthase, human monocytes and macrophages

DOI: 10.1134/S0006297907070127